Tag: ado-trastuzumab emtansine

Genentech gets Kadcyla FDA approval for post-surgery treatment of HER2+ EBC

pharmanewsdaily- May 5, 2019

Kadcyla FDA approval : Roche subsidiary Genentech has secured approval from the US Food and Drug Administration (FDA) for its breast cancer drug Kadcyla (ado-trastuzumab ... Read More